Analysis
PublicCHARLES STARK DRAPER LABORATORY, INC., THE holds $1.9B across 180 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 28, 2028 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMALL INTESTINE-IMMUNE ORGAN-ON-CHIP MODELS, MOLECULAR ASSAYS, OMICS-BASED TECHNOLOGIES, ADVANCED ANALYTICAL METHODS FOR BIOMARKER DISC
Recompete timing
PublicCurrent PoP ends Sep 28, 2028 (774 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 28, 2027.
Watch this contract — one email →Incumbent footprint
Public recordCHARLES STARK DRAPER LABORATORY, INC., THE — $1.9B obligated across 180 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open CHARLES STARK DRAPER LABORATORY, INC., THE’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50123C00042?
75A50123C00042 (ADVANCE THE DEVELOPMENT OF A MEDICAL COUNTERMEASURE (MCM) EVALUATION PLATFORM THAT CONSISTS OF VASCULAR-IMMUNE AND SMAL…) is a Department of Health and Human Services (HHS) award with an estimated value of $36M, currently held by CHARLES STARK DRAPER LABORATORY, INC., THE. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50123C00042?
CHARLES STARK DRAPER LABORATORY, INC., THE is the incumbent with $1.9B across 180 related awards in SCOUT’s public footprint. The current period of performance ends Sep 28, 2028.
When does 75A50123C00042 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 28, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →